Lake Street Advisors Group LLC Makes New $225,000 Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Lake Street Advisors Group LLC purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 379 shares of the biotechnology company’s stock, valued at approximately $225,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Illinois Municipal Retirement Fund raised its position in Axon Enterprise by 94.2% during the fourth quarter. Illinois Municipal Retirement Fund now owns 13,293 shares of the biotechnology company’s stock worth $7,900,000 after acquiring an additional 6,449 shares in the last quarter. Los Angeles Capital Management LLC raised its position in Axon Enterprise by 482.3% during the fourth quarter. Los Angeles Capital Management LLC now owns 10,330 shares of the biotechnology company’s stock worth $6,139,000 after acquiring an additional 8,556 shares in the last quarter. Synergy Financial Group LTD raised its position in shares of Axon Enterprise by 32.9% in the fourth quarter. Synergy Financial Group LTD now owns 993 shares of the biotechnology company’s stock valued at $590,000 after purchasing an additional 246 shares during the period. IFP Advisors Inc raised its position in shares of Axon Enterprise by 7.6% in the fourth quarter. IFP Advisors Inc now owns 952 shares of the biotechnology company’s stock valued at $566,000 after purchasing an additional 67 shares during the period. Finally, Colonial River Investments LLC raised its position in shares of Axon Enterprise by 5.5% in the fourth quarter. Colonial River Investments LLC now owns 1,573 shares of the biotechnology company’s stock valued at $935,000 after purchasing an additional 82 shares during the period. 79.08% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on AXON. TD Cowen began coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. Barclays set a $726.00 price objective on shares of Axon Enterprise and gave the company an “overweight” rating in a research report on Thursday. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $587.38.

Axon Enterprise Trading Up 0.6 %

Shares of Axon Enterprise stock opened at $528.45 on Friday. The company has a market capitalization of $40.30 billion, a price-to-earnings ratio of 136.55, a PEG ratio of 5.17 and a beta of 1.05. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The firm’s 50-day moving average price is $609.55 and its two-hundred day moving average price is $523.20.

Insiders Place Their Bets

In other news, insider Jeffrey C. Kunins sold 1,035 shares of the stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the transaction, the insider now owns 124,243 shares of the company’s stock, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 8,711 shares of company stock worth $5,631,561 over the last ninety days. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.